Targovax Receives 2017 Nordic Stars Award
Oslo, Norway, 14 September 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that they are one of three companies to have been selected for this year's Nordic Stars Awards, presented by SwedenBIO. This award is given to recognize life science companies in the Nordic region which demonstrate exemplary innovation and entrepreneurial prowess. The prize was awarded at the closing address of the Nordic Life Science Days event on Thursday 14 September 2017. Øystein